KOR

e-Article

Sa1640 LONG-TERM SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS; FINAL 8-YEAR RESULTS OF 2 PHASE 3 STUDIES